Altimmune ALT
NASDAQ ALT
$2.73 -0.03 (-1.09%)
At close: Oct 2, 2026 · 4:00 PM EDT

Altimmune (ALT) Non Operating Investment Income (2017 - 2018)

Updated

Altimmune's Non Operating Investment Income was $806,224 in Q3 2018, compared with -$508,316 a year earlier.

Analysis

Altimmune (ALT) Non Operating Investment Income (2017 - 2018) Analysis & Trends

On a trailing twelve-month basis, Altimmune's Non Operating Investment Income was -$2.27 million through Sep 30, 2018; for FY2017, it was $97,763.

  • Quarterly Non Operating Investment Income has moved between -$5.23 million (Q2 2018) and $1.55 million (Q1 2018) over five years.
  • Per Business Quant data, ALT's Non Operating Investment Income in the three quarters before Q3 2018 was -$5.23 million (Q2 2018), $1.55 million (Q1 2018) and $606,079 (Q4 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Altimmune 530.91 Mn 530.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 806,224.00
Jun 30, 2018 -5.23 Mn
Mar 31, 2018 1.55 Mn
Dec 31, 2017 606,079.00
Sep 30, 2017 -508,316.00
API Access

Altimmune Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ALT&period=max&api_key=YOUR_API_KEY